Company: BWAY
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001171843-25-002347
Chunk: 196

Company: Brainsway Ltd.
Filing Date: 2025-04-22
Form: 20-F
Item: Item 16G
Chunk 196
---
ITEM 16G. CORPORATE GOVERNANCE
Nasdaq Stock Listing Rules and Home Country Practices
 
As a foreign private issuer whose ADSs are listed on The Nasdaq Global Market, we are permitted to follow certain home country corporate governance practices instead of certain requirements of the rules of The Nasdaq Global Market. Pursuant to the “foreign private issuer exemption”:

●                            we established a quorum requirement such that the quorum for any meeting of shareholders                        
     is two or more shareholders holding at least 33 and 1/3% of our voting rights, which complies with Nasdaq requirements; however, if the 
    meeting is adjourned for lack of quorum, the quorum for such adjourned meeting will be any number of shareholders, instead of 33 and 1/3%
                                                              of our voting rights;                                                          
---------------------------------------------------------------------------------------------------------------------------------------------

 150 
-----

●                               we also follow Israeli corporate governance practice in lieu of Nasdaq Marketplace Rule                             
      5635(c), which requires shareholder approval for certain dilutive events (such as issuances that will result in a change of control, certain  
        transactions other than a public offering involving issuances of a 20% or greater interest in us and certain acquisitions of the shares     
      or assets of another company) and prior to an issuance of securities when a stock option or purchase plan is to be established or materially  
      amended or other equity compensation arrangement made or materially amended, pursuant to which stock may be acquired by officers, directors,  
    employees or consultants. By contrast, under the Israeli Companies Law, shareholder approval is required (subject to certain limited exceptions)
         for, among other things: (a) transactions with directors concerning the terms of their service (including indemnification, exemption,      
      and insurance for their service or for any other position that they may hold at a company); (b) extraordinary transactions with controlling   
        shareholders of publicly held companies; (c) terms of office, and employment or other engagement of our controlling shareholder, if any,    
              or such controlling shareholder’s relative; (d) transactions with the company’s Chief Executive Officer with respect to his           
         or her compensation, whether in accordance with the approved compensation policy of the company or not, or transactions with officers      
         of the company not in accordance with the approved compensation policy; (e) the compensation policy of the company for office holders;     
         and (f) certain private placements involving the issuance of 20% or more of our total